Edwards Lifesciences Reports Double-Digit Pay Increases for Executives and Median Employee

Why It Matters

The expanded pay packages signal Edwards’ confidence in retaining top talent amid rapid growth, while the shrinking pay gap addresses investor and regulatory scrutiny of executive compensation in medtech.

Key Takeaways

• CEO Bernard Zovighian earned $17.5 M in 2025, a 19% increase
• Median employee salary rose 21% to $89,827, narrowing pay gap
• CEO‑to‑median pay ratio fell to 194:1, down from 197:1
• Company revenue hit $6.1 B in 2025, up 11.5% YoY
• CFO Scott Ullem will step down, succeeded by Doretta Mistras

Pulse Analysis

Edwards Lifesciences’ latest proxy filing shines a spotlight on compensation trends in the high‑growth medtech sector. With revenue climbing to $6.1 billion—a solid 11.5% year‑over‑year gain—the company is using aggressive pay incentives to lock in the leadership that drove its structural‑heart device success. The CEO’s $17.5 million package, bolstered by stock and option awards, aligns with a broader industry pattern where equity‑heavy remuneration rewards long‑term innovation and shareholder returns.

Beyond the executive suite, the 21% jump in median employee wages to $89,827 reflects Edwards’ effort to stay competitive in a tight talent market for engineers and clinicians. By raising base salaries and offering deferred‑compensation matches, the firm aims to curb turnover that can stall product pipelines. The narrowing CEO‑to‑median pay ratio to 194:1 also helps mitigate criticism from investors and ESG analysts who monitor income disparity as a proxy for governance quality.

The leadership transition in the finance function adds another layer of strategic focus. Outgoing CFO Scott Ullem’s departure and the appointment of former pharma CFO Doretta Mistras signal a push for fresh financial discipline as Edwards expands its global footprint. Together, the compensation uplift, revenue growth, and governance changes illustrate how leading medtech firms balance rewarding top talent with broader stakeholder expectations, a dynamic that will likely shape compensation disclosures across the industry.